Majority of Life Sciences Leaders Implement AI Governance Structures to Engage with Emerging Technologies

Empowering the Future: AI Governance in Life Sciences

A recent publication from the Responsible AI in Life Sciences (RAIL) Report 2026 reveals that a significant 64% of executives in the life sciences sector are actively pursuing the establishment of governance structures for artificial intelligence (AI). This trend reflects a substantial readiness within the industry to integrate AI into various operational domains, including commercial settings, medical research, and patient care. The report is grounded in discussions from roundtable meetings and surveys conducted among leadership in pharmaceutical, biotechnology, and medical device sectors.

AI Governance Overview

The study conducted by ACTO Technologies indicates that while the life sciences industry is poised to utilize AI more extensively, trust remains a crucial barrier to widespread implementation. A staggering 58% of executives admitted that they believe the sector lacks clear standards for responsible AI practices. This lack of standardized governance heightens hesitations regarding effective AI deployment.

The perception of governance as a dynamic operational model is significant. Leaders describe it as an ongoing process that transcends initial approvals, requiring designated accountable individuals, transparent escalation pathways, and standardized operating procedures (SOPs). Despite this understanding, over a third of organizations lack a defined governance framework and rely on ad hoc IT approvals instead.

Trust: The Cornerstone of AI Deployment

Trust emerges as a vital criterion influencing the speed and extent of AI adoption. Internal challenges, such as regulatory and compliance issues (21%), are viewed as the primary obstacles, overshadowing technical readiness, which was cited by only 9% of executives. Notably, when evaluating AI pilot projects, leaders prioritize trust and acceptance (24%) over factors such as efficiency (23%). This shift signals an evolution in expectations as the industry navigates the complexities of AI deployment.

Interestingly, while 68% of executives actively participate in AI initiatives, 54% express concerns about the way AI is utilized within their organizations. This duality points to a broader need for alignment between personal confidence in AI technology and organizational practices surrounding its use.

The Need for Clear Accountability

In discussions regarding accountability, opinions diverge regarding who should be held responsible for the actions of an AI agent. Responses varied, with various stakeholders—end users (34%), legal and compliance departments (28%), and external AI providers (22%)—all being mentioned, highlighting the ambiguity of accountability in AI applications. Almost a quarter of companies (23%) do not monitor or discuss unauthorized AI applications, illuminating a gap that can potentially erode trust in AI systems.

The Shift from 'Where to Start?' to 'What Next?'

As organizations mature in their AI strategies, the focus is transitioning from identifying initial touchpoints to determining subsequent developmental phases. Leaders are eager to harness AI's potential for performance enhancement, with 79% agreeing that measures of AI risks and return on investment should gauge current human performance standards. Improved outcomes and results (29%) emerged as the most anticipated benefits, far outpacing budget savings (10%) or risk mitigation (8%).

The most advanced AI adopters are strategically assessing each application based on value and difficulty in management. Initiatives are underway to streamline manageable tasks before addressing more intricate challenges, such as system interoperability and comprehensive product launching.

Emphasis on Human Judgment and Capacity

Amid all advancements, human involvement remains the most challenging factor in AI implementation. Conversations consistently spoke to the significance of change management, emphasizing the need for employees to focus on judgment, interpersonal skills, and strategic depth. To adapt to evolving roles necessitated by AI, redefining job descriptions to distinguish responsibilities and direct human tasks is imperative.

A Call for Standardized Trust Metrics

To address the pressing need for mutual benchmarks in the industry, the RAIL Score is introduced. This evaluation metric assesses AI systems based on governance, security, testing, human-centric design, value creation, and orchestration. Each component receives a high, medium, or low grading to establish its trustworthiness for biopharmaceutical applications. This allows for informed evaluations based on factual standards rather than supplier claims.

The RAIL report aims to assist organizations in fostering responsible AI usage, ensuring that safety and governance prerequisites are strictly upheld across the board. As the industry confronts these crucial developments, the importance of accessing and utilizing responsible AI frameworks becomes undeniably clear.

Additionally, for those who want to delve deeper into the insights of this report, a free copy of the RAIL 2026 report and practical tools are available at acto.com/RAIL.

As executives gear up for further exploration of responsible AI applications, attendance at the upcoming webinar on November 4, 2026, promises to provide further clarity and perspective on the evolving landscape of agentic AI.